Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells-Reference-Cited by-同舟云学术

Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells

Published:2013-05 Issue:5 Volume:93 Page:713-721
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

Sabbagh Laurent,Andreeva Daniela,Laramée Geneviève Dubeau,Oussa N. A. Eustache,Lew Déborah,Bisson Nicolas,Soumounou Youssouf,Pawson Tony,Watts Tania H.

Funder

Maisonneuve-Rosemont Hospital Foundation

Leukemia and Lymphoma Society of Canada

Canadian Cancer Society

Leukemia and Lymphoma Society

Université de Montréal

Cole Foundation

University of Toronto

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference46 articles.

1. Apoptosis and the homeostatic control of immune responses;Hildeman;Curr. Opin. Immunol.,2007

2. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival;Sabbagh;Proc. Natl. Acad. Sci. USA,2006

3. Signalling pathways of the TNF superfamily: a double-edged sword;Aggarwal;Nat. Rev. Immunol.,2003

4. TRAF-mediated TNFR-family signaling;Ha;Curr. Protoc. Immunol. Chapter,2009

5. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival;Pulle;J. Immunol.,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systems and computational biology perspective on advancing CAR therapy;Seminars in Cancer Biology;2023-09

2. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects;Science Advances;2023-08-18

3. TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation;Immunity;2023-07

4. CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary;Cancer Discovery;2022-12-28

5. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes;Frontiers in Immunology;2022-07-22